TrialHaematologica2021

Response-adapted therapy with infusional EPOCH chemotherapy plus rituximab in HIV-associated, B-cell non-Hodgkin's lymphoma.

Joseph A Sparano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.